Cocrystal Pharma Inc. (NASDAQ: COCP) stock is falling in after-market, Why is this happening?

Dogecoin

 Cocrystal Pharma (Nasdaq: COCP) a clinical-stage biotechnology company specializing to develop and manufacture unique antiviral therapeutics targeting the replication machinery of several viruses such as influenza, coronaviruses, and hepatitis C, announced that it has complied for an underwriting agreement with H.C. Wainwright & Co., LLC.COCP stock surged immensely adjacent to the news. At last check in […]